The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells
Hua Yang(University of Hawaiʻi at Mānoa), Saı̈d M. Sebti(Virginia Commonwealth University)
Cited by 27
Related Papers
Discovery of Marinopyrrole A (Maritoclax) as a Selective Mcl-1 Antagonist that Overcomes ABT-737 Resistance by Binding to and Targeting Mcl-1 for Proteasomal Degradation
|Journal of Biological Chemistry|2012|156
Protein Prenylation Constitutes an Endogenous Brake on Axonal Growth
|Cell Reports|2016|61
Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer
|Clinical Cancer Research|2021|34